Wood, R.
Taylor-Stokes, G.
Lees, M.
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 20 February 2018
Accepted: 9 August 2018
First Online: 18 August 2018
Compliance with ethical standards
: The study protocol was approved by a central Institutional Review Board (Freiburg Ethics Commission International—Ref 015/1196).
: Robert Wood and Gavin Taylor-Stokes are employees of Adelphi Real World, a consultancy to the health insurance and life science industries. Michael Lees was an employee of Bristol Myers Squibb, the sponsor of this research and a global biopharmaceutical company that researches and develops medicines for NSCLC, at the time the study was conducted.